Adcendo ApS
CVR 38780093 · Private limited company (ApS) · Active · Low risk
Adcendo ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 743k and a net result of DKK -383k. CEO: Pernille Kristine Hemmingsen, Dominik Mumberg, Lone Harild Ottesen, Lasse René Sørensen.
Bankruptcy risk for Adcendo ApS
0.2%
probability of bankruptcy within 12 months
Low risk
0.1 × the average (1.41%) · higher risk than 44% of active Danish companies
Lowest riskHighest risk
Increases the risk
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Reduces the risk
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Number of CEOs3+ · bankruptcy rate 4.0%0.46×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38780093
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (9 years)
- Address
- c/o Symbion Frederiksberg, Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 1.4m
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 84.2% |
| Current ratio | 321% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 11 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -255k | DKK -207k |
| Net profit | DKK -383k | DKK -254k |
| Equity | DKK 743k | DKK 691k |
| Total assets | DKK 882k | DKK 747k |
| Cash | DKK 417k | – |
| Short-term debt | DKK 139k | – |
| Avg. employees | 54 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 133 | ||
| 1 Jan 2024 – 31 Dec 2024 | 164 | ||
| 1 Jan 2023 – 31 Dec 2023 | 109 | ||
| 1 Jan 2022 – 31 Dec 2022 | 109 | ||
| 1 Jan 2021 – 31 Dec 2021 | 142 | ||
| 1 Jan 2020 – 31 Dec 2020 | 104 | ||
| 1 Jan 2019 – 31 Dec 2019 | 143 | ||
| 1 Jul 2017 – 31 Dec 2018 | 147 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Pernille Kristine Hemmingsen | Current | |
| CEO | Dominik Mumberg | Current | |
| CEO | Lone Harild Ottesen | Current | |
| CEO | Lasse René Sørensen | Current | |
| CEO | Niels Behrendt | ||
| CEO | Lars Henning Milman Engelholm | ||
| CEO | Christoffer Fagernæs Nielsen | ||
| CEO | Henrik Stage | ||
| CEO | Carmel Martina Lynch | ||
| Board | Pieter Jeroen Bakker | Current | |
| Board | Ohad Hammer | Current | |
| Board | Iyona Rajkomar | Current | |
| Board | Michael Friedrich Pehl | Current | |
| Board | Cariad Chester | Current | |
| Board | Nandita Shangari | Current | |
| Board | Chun Chi Carolyn Ng | Current | |
| Board | Laura Kay Shawver | Current | |
| Board | Roy Dennis Baynes | Current | |
| Board | Ksenija Pavletic Aranicki | Current | |
| Board | Rajul Krishna Jain | Current | |
| Board | John Sørensen Haurum | ||
| Board | Lars Henning Milman Engelholm | ||
| Board | Joël Jean-Mairet | ||
| Board | Lisanne Darunii de Jongh | ||
| Board | Mårten Steen | ||
| Board | Reza Halse | ||
| Board | Carl Johan Rutger Kilander | ||
| Board | Edwin William de Graaf | ||
| Board | Joël Jean-Mairet | ||
| Board | Joel Charles Barrish | ||
| Owner (5%) | Novo Holdings A/S | Current | |
| Owner (5%) | YSIOS BIOFUND III, FCRE | Current | |
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | Current | |
| Owner (5%) | Healthcap VIII L.P. | Current | |
| Owner (5%) | RA Capital Healthcare Fund, L.P. | Current | |
| Owner (5%) | Pontifax (Israel) VI L.P. | Current | |
| Owner (5%) | Dawn Holdco SCSp | Current | |
| Owner (10%) | TCG Crossover Fund II, L.P. | Current | |
| Owner (5%) | TPG LSI Rise Athletic S.à r.l. | Current | |
| Owner (5%) | Jeito II S.L.P | Current | |
| Owner (25%) | Niels Behrendt | ||
| Owner (25%) | Lars Henning Milman Engelholm | ||
| Owner (25%) | Christoffer Fagernæs Nielsen | ||
| Owner (25%) | Next Stage Ventures ApS | ||
| Owner (25%) | CFN Holding ApS | ||
| Owner (25%) | Engelholm ApS | ||
| Owner (25%) | NB 2017 ApS | ||
| Owner (5%) | Novo Holdings A/S | ||
| Owner (10%) | Next Stage Ventures ApS | ||
| Owner (10%) | CFN Holding ApS | ||
| Owner (10%) | Engelholm ApS | ||
| Owner (10%) | NB 2017 ApS | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (5%) | Healthcap VIII L.P. | ||
| Owner (10%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (10%) | Novo Holdings A/S | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (5%) | Healthcap VIII L.P. | ||
| Owner (15%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (10%) | YSIOS BIOFUND III, FCRE | ||
| Owner (10%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (10%) | Healthcap VIII L.P. | ||
| Owner (15%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (5%) | Pontifax (Israel) VI L.P. | ||
| Owner (5%) | Pontifax (Cayman) VI L.P | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (10%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (5%) | KKR DAWN AGGREGATOR L.P. | ||
| Owner (5%) | Dawn Holdco SCSp | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (5%) | Pontifax (Israel) VI L.P. | ||
| Owner (5%) | Pontifax (Cayman) VI L.P | ||
| Owner (5%) | Dawn Holdco SCSp | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (10%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (10%) | Healthcap VIII L.P. | ||
| Owner (10%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (5%) | Pontifax (Israel) VI L.P. | ||
| Owner (5%) | Pontifax (Cayman) VI L.P | ||
| Owner (5%) | Dawn Holdco SCSp | ||
| Owner (10%) | Novo Holdings A/S | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (5%) | Healthcap VIII L.P. | ||
| Owner (10%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (5%) | Pontifax (Israel) VI L.P. | ||
| Owner (5%) | Dawn Holdco SCSp | ||
| Owner (5%) | TCG Crossover Fund II, L.P. | ||
| Owner (10%) | Novo Holdings A/S | ||
| Owner (5%) | YSIOS BIOFUND III, FCRE | ||
| Owner (5%) | Coöperatieve Gilde Healthcare V U.A. | ||
| Owner (5%) | Healthcap VIII L.P. | ||
| Owner (5%) | RA Capital Healthcare Fund, L.P. | ||
| Owner (5%) | Pontifax (Israel) VI L.P. | ||
| Owner (5%) | Dawn Holdco SCSp | ||
| Owner (10%) | TCG Crossover Fund II, L.P. | ||
| Owner (5%) | TPG LSI Rise Athletic S.à r.l. | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Niels Behrendt | Current | |
| Founder | Lars Henning Milman Engelholm | Current | |
| Founder | Christoffer Fagernæs Nielsen | Current | |
| Founder | Next Stage Ventures ApS | Current |
The CEOs' other companies
Pernille Kristine Hemmingsen – 1 other companies
- GENMAB A/S Active
Lone Harild Ottesen – 1 other companies
- GENE HOUSE ApS Opløst
Lars Henning Milman Engelholm – 1 other companies
- PanTarg ApS Active
Christoffer Fagernæs Nielsen – 1 other companies
- Bumblebee Biotech ApS Active
Henrik Stage – 10 other companies, of which 1 bankrupt
- CARAXESS A/S Bankrupt 22 Nov 2002
- Biomia ApS Active
- Fuse Vectors ApS Active
- NSF VI Helgeshøj Allé ApS Active
- RHOVAC ApS Active
- RICC A/S Active
- ResoTher Pharma A/S Active
- SYNACT PHARMA ApS Active
- Skape Bio ApS Active
- iNotify ApS Active
Address history (3 moves)
| c/o Symbion Frederiksberg, Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o Symbion Fuglebakken, Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o BioInnovation Institute, Ole Maaløes Vej 3, 2200 København N | |
| c/o Next Stage Ventures ApS, Gl Strandvej 250, 3050 Humlebæk |
Former names
| Adcendo ApS | – now |
| ADCendo ApS | – |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
- Details ApS Active
Similar companies in Frederiksberg
- Catalyst Vaccination A/S Frederiksberg
- RefuelBio ApS Frederiksberg
- BioMomentum Advisors ApS Frederiksberg
- Oak Mountain Consulting ApS Frederiksberg
- Biotinia ApS Frederiksberg
- Nordic BioVentures ApS Frederiksberg C
- Zevra Denmark A/S Frederiksberg
- BioPhenyx ApS Frederiksberg
- BioSpringbok ApS Frederiksberg
- Orbis Medicines ApS Frederiksberg
- Epoqe Pharma ApS Frederiksberg
- SJM IP ApS Frederiksberg C
Questions and answers about Adcendo ApS
Has Adcendo ApS gone bankrupt?
No, Adcendo ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Adcendo ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Adcendo ApS?
Pernille Kristine Hemmingsen, Dominik Mumberg, Lone Harild Ottesen, Lasse René Sørensen are the CEOs of Adcendo ApS.
Who is the auditor of Adcendo ApS?
Adcendo ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Adcendo ApS founded?
Adcendo ApS was founded on 1 July 2017.
What is the equity of Adcendo ApS?
Equity was DKK 743k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.